Ben Tre Pharmaceutical JSC (HOSE:DBT)
Vietnam · Delayed Price · Currency is VND 13,100
0.00 (0.00%)
At close: Nov 3, 2026
HOSE:DBT Ratios and Metrics
Market cap in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
| 287,771 | 247,132 | 250,474 | 199,171 | 160,993 | 162,983 | |
Market Cap Growth | 19.09% | -1.33% | 25.76% | 23.71% | -1.22% | -24.38% |
Enterprise Value | 758,986 | 805,383 | 604,689 | 553,386 | 394,589 | 347,380 |
Last Close Price | 13100.00 | 11250.00 | 11401.87 | 10001.64 | 8008.53 | 7447.13 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
PE Ratio | 10.67 | 19.23 | 18.98 | 15.36 | 7.53 | 8.07 |
PS Ratio | 0.33 | 0.29 | 0.29 | 0.25 | 0.20 | 0.20 |
PB Ratio | 0.97 | 0.85 | 0.88 | 0.80 | 0.68 | 0.68 |
P/TBV Ratio | 1.14 | 1.04 | 1.12 | 0.86 | 0.93 | 1.02 |
P/OCF Ratio | 1.92 | - | - | 550.74 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
EV/Sales Ratio | 0.87 | 0.94 | 0.70 | 0.68 | 0.49 | 0.43 |
EV/EBITDA Ratio | 12.05 | 12.85 | 9.13 | 7.28 | 9.19 | 8.62 |
EV/EBIT Ratio | 16.46 | 17.89 | 12.31 | 8.25 | 13.32 | 12.73 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
Debt / Equity Ratio | 1.59 | 1.89 | 1.92 | 1.92 | 1.37 | 0.92 |
Debt / EBITDA Ratio | 7.49 | 8.75 | 8.23 | 6.27 | 7.60 | 5.49 |
Debt / FCF Ratio | 3.24 | - | - | - | - | - |
Net Debt / Equity Ratio | 1.55 | 1.68 | 1.74 | 1.68 | 1.03 | 0.58 |
Net Debt / EBITDA Ratio | 7.31 | 7.77 | 7.48 | 5.48 | 5.69 | 3.43 |
Net Debt / FCF Ratio | 3.16 | -35.74 | -12.12 | -59.84 | -3.02 | -6.47 |
Asset Turnover | 0.94 | 0.87 | 0.94 | - | 1.22 | 1.31 |
Inventory Turnover | 1.29 | 1.17 | 1.26 | - | 2.71 | 3.55 |
Quick Ratio | 0.30 | 0.43 | 0.32 | 0.39 | 0.51 | 0.69 |
Current Ratio | 1.15 | 1.12 | 1.10 | 1.16 | 1.17 | 1.18 |
Return on Equity (ROE) | 9.84% | 5.01% | 4.61% | - | 10.11% | 8.75% |
Return on Assets (ROA) | 3.09% | 2.84% | 3.32% | - | 2.81% | 2.76% |
Return on Invested Capital (ROIC) | 3.91% | 3.47% | 4.09% | 8.86% | 5.57% | 5.92% |
Return on Capital Employed (ROCE) | 14.80% | 14.50% | 15.40% | 25.90% | 11.90% | 11.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
Earnings Yield | 9.37% | 5.75% | 5.82% | 8.13% | 13.29% | 12.39% |
FCF Yield | 50.67% | -5.51% | -16.32% | -3.49% | -50.28% | -13.09% |
Payout Ratio | - | - | - | - | 63.23% | 90.84% |
Buyback Yield / Dilution | 0.00% | -11.98% | -9.97% | - | - | - |
Total Shareholder Return | 6.12% | -11.98% | -9.97% | - | - | - |